Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome
This protocol concerns the approach to the localization and management of the tumor in
patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used
to localize the tumor and the subsequent management of the tumor.
- INCLUSION CRITERIA:
New patients will be evaluated initially as described in the protocol entitled,
"Diagnostic evaluation of patients with suspected abnormalities of gastric secretion"
Only those patients that are being treated under the protocol entitled, "Medical Therapy
of Zollinger-Ellison Syndrome" (protocol # 89-DK-0015) will be entered into this tumor
localization and management protocol.
Type of Study:
Stephen A Wank, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
United States: Federal Government
- Zollinger Ellison Syndrome
- Islet Cell Tumors
- Zollinger-Ellison Syndrome
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Bethesda, Maryland 20892|